Search results
Results From The WOW.Com Content Network
Gestational diabetes is a condition in which a woman without diabetes develops high blood sugar levels during pregnancy. [2] Gestational diabetes generally results in few symptoms; [2] however, obesity increases the rate of pre-eclampsia, cesarean sections, and embryo macrosomia, as well as gestational diabetes. [2]
For gestational diabetes, the American College of Obstetricians and Gynecologists (ACOG) recommends a two-step procedure, wherein the first step is a 50 g glucose dose. [ 12 ] [ 16 ] If after 1 hour the blood glucose level is more than 7.8 mmol/L (140 mg/dL), [ 12 ] it is followed by a 100 g glucose dose. [ 12 ]
Obstetrics & Gynecology is the official publication of ACOG. It is popularly known as "The Green Journal". [7] In 1986, the organization successfully challenged an anti-abortion law in Pennsylvania before the U.S. Supreme Court in Thornburgh v. American College of Obstetricians and Gynecologists. [8]
Pre-gestational diabetes can be classified as Type 1 or Type 2 depending on the physiological mechanism. Type 1 diabetes mellitus is an autoimmune disorder leading to destruction of insulin-producing cell in the pancreas; type 2 diabetes mellitus is associated with obesity and results from a combination of insulin resistance and insufficient insulin production.
Maternal insulin resistance can lead to gestational diabetes. Increased liver metabolism is also seen, with increased gluconeogenesis to increase maternal glucose levels. Increased liver metabolism is also seen, with increased gluconeogenesis to increase maternal glucose levels.
The American Journal of Obstetrics and Gynecology (AJOG) is a peer reviewed journal of obstetrics and gynecology.It is popularly called the "Gray Journal". Since 1920, AJOG has continued the American Journal of Obstetrics and Diseases of Women and Children, which began publishing in 1868.
The Ballard Maturational Assessment, Ballard Score, or Ballard Scale, is a commonly used technique of gestational age assessment. It was devised by Dr Jeanne L. Ballard, professor emeritus of Pediatrics, Obstetrics and Gynecology at the University of Cincinnati College of Medicine.
The AIDA software is intended to serve as an educational support tool and can be used by anyone — person with diabetes, relative of a patient, health care professional (doctor, nurse, clinical diabetes educator, dietician, pharmacist, etc.), or student — even if they may have minimal knowledge of the pathophysiology of diabetes mellitus.